NEWS RELEASE

Department of Defense
Defense Health Agency Research and Development-Medical Research and Development Command
Congressionally Directed Medical Research Programs

Released: March 27, 2025

CDMRP Announces Research Funding for Fiscal Year 2025

FORT DETRICK, Md. - On March 15, 2025, the President signed into law the "Full-Year Continuing Appropriations and Extensions Act of 2025," which includes $650M in funding for the Congressionally Directed Medical Research Programs.

Congress provided further direction for CDMRP program-level funding to the Secretary of Defense in Project Level Adjustment Tables to Accompany Division A, Title IV, Department of Defense, H.R. 1968, Full-Year Continuing Appropriations and Extensions Act.

The FY25 funded programs are as follows:

• Alzheimer's Research Program - $15.0 million
• Amyotrophic Lateral Sclerosis Research Program - $40.0 million
• Breast Cancer Research Program - $130.0 million
• Duchenne Muscular Dystrophy Research Program - $12.5 million
• Melanoma Research Program - $40.0 million
• Military Burn Research Program - $10.0 million
• Ovarian Cancer Research Program - $15.0 million
• Peer Reviewed Cancer Research Program (18 topics) - $130.0 million
• Peer Reviewed Medical Research Program (42 topics) - $150.0 million
• Prostate Cancer Research Program - $75 million
• Rare Cancers Research Program - $17.5 million
• Toxic Exposures Research Program - $15.0 million

Pre-announcements and funding opportunity announcements will be forthcoming. Pre-announcements will provide a brief overview of anticipated funding mechanisms within each program. Funding opportunity announcements will include detailed descriptions of award mechanism intent, evaluation criteria, submission requirements, and deadlines. Each funding opportunity announcement will be posted on CDMRP https://cdmrp.health.mil, Grants.gov https://www.grants.gov, and eBRAP https://eBRAP.org.

For email notification when pre-announcements and funding opportunity announcements are released, subscribe to program-specific news and updates under "Email Subscriptions" on the eBRAP homepage.

For more information about the CDMRP, our research programs, and research highlights please visit the website at https://cdmrp.health.mil.

Point of Contact:
CDMRP Public Affairs
301-619-7783
dha.detrick.cdmrp.mbx.public-affairs@health.mil

Top of Page